Liver cirrhosis - The Lancet
ACE Inhibitors: Drug List, Side Effects, Mechanism of Action, Example Medications, Contraindications — EZmed
Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients
The potential therapeutic use of renin–angiotensin system inhibitors in the treatment of inflammatory diseases - Ranjbar - 2019 - Journal of Cellular Physiology - Wiley Online Library
PDF) Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study
COVID‐19 and Liver Cirrhosis: Focus on the Nonclassical Renin‐Angiotensin System and Implications for Therapy - Sansoè - 2021 - Hepatology - Wiley Online Library
Enalapril improves obesity associated liver injury ameliorating systemic metabolic markers by modulating Angiotensin Converting Enzymes ACE/ACE2 expression in high-fat feed mice - ScienceDirect
Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease: JACC Review Topic of the Week | Journal of the American College of Cardiology
Renin angiotensin system in liver diseases: Friend or foe?
Role of Chymase in the Development of Liver Cirrhosis and Its Complications: Experimental and Human Data | PLOS ONE
Evidence-based clinical practice guidelines for Liver Cirrhosis 2020 | SpringerLink
Hepatic Antifibrotic Pharmacotherapy: Are We Approaching Success?
Heart Failure and Liver Disease: Cardiohepatic Interactions - ScienceDirect
Angiotensin-converting enzyme inhibitors prevent liver-related events in nonalcoholic fatty liver disease,Hepatology - X-MOL
JCM | Free Full-Text | Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options
The systemic and hepatic alternative renin–angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation | Scientific Reports
Prescribing Medications in Patients with Decompensated Liver Cirrhosis
Renal Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Liver Cirrhosis: A Nationwide Cohort Study
The pharmacokinetics of perindopril in patients with liver cirrhosis. - Abstract - Europe PMC
Treatment of hypertension in patients with peptic ulcer and liver pathology DM Leonid Lazebnik DM Leonid Lazebnik DM Olga Mikheeva The Central Research. - ppt download
JCM | Free Full-Text | Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options
The Korean Journal of Internal Medicine
Renin-angiotensin-aldosterone inhibitors in the reduction of portal pressure: a systematic review and meta-analysis. | Semantic Scholar
